Andrea Poirier Forgy, MD
Obstetrics & Gynecology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Forgy’s office at (650) 903-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G83161 · Current
Licensed to practise in California · since 1996 · expires 2028-01-31 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Drugs they prescribed that Part D paid
$13,429
Pharmacies billed $13,429 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 133) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
109 generic and 24 brand-name prescriptions · $13,429 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 31 | $1,124 | $36 |
| Acyclovir | 15 | $944 | $63 |
| Progesterone | 13 | $579 | $45 |
Year by year
| 2024 | 133 | 54 | 0% (0) | 18% | $13,429 |
| 2023 | 159 | 63 | None | 16% | $14,403 |
| 2022 | 233 | 77 | 0% (0) | 13% | $17,792 |
| 2021 | 225 | 80 | 0% (0) | 16% | $17,200 |
| 2020 | 239 | 85 | 0% (0) | 15% | $20,161 |
| 2019 | 208 | 78 | 0% (0) | 18% | $22,415 |
| 2018 | 198 | 72 | 0% (0) | 32% | $19,714 |
| 2017 | 194 | 71 | 0% (0) | 34% | $27,649 |
| 2016 | 160 | 65 | None | 44% | $22,645 |
| 2015 | 197 | 72 | None | 45% | $24,283 |
| 2014 | 210 | 82 | None | 41% | $20,973 |
| 2013 | 261 | 99 | None | 52% | $25,630 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Estring | 14 | $8,322 | $594 |
| Yuvafem | 11 | $1,432 | $130 |
| Estradiol | 43 | $1,307 | $30 |
| Acyclovir | 12 | $447 | $37 |
| Medroxyprogesterone Acetate | 12 | $168 | $14 |
| Alendronate | 12 | $124 | $10 |
2022: 6 drugs
| Estring | 13 | $7,354 | $566 |
| Yuvafem | 15 | $2,418 | $161 |
| Estradiol | 66 | $1,813 | $27 |
| Progesterone | 13 | $506 | $39 |
| Medroxyprogesterone Acetate | 19 | $335 | $18 |
| Alendronate | 12 | $125 | $10 |
2021: 6 drugs
| Estradiol | 50 | $2,330 | $47 |
| Yuvafem | 11 | $1,537 | $140 |
| Adacel Tdap | 11 | $550 | $50 |
| Medroxyprogesterone Acetate | 17 | $291 | $17 |
| Alendronate | 12 | $125 | $10 |
| Fluconazole | 11 | $69 | $6 |
2020: 7 drugs
| Estring | 12 | $6,424 | $535 |
| Estradiol | 55 | $3,089 | $56 |
| Climara | 11 | $1,658 | $151 |
| Progesterone | 18 | $655 | $36 |
| Acyclovir | 12 | $429 | $36 |
| Medroxyprogesterone Acetate | 20 | $412 | $21 |
| Alendronate | 17 | $177 | $10 |
2019: 5 drugs
| Estring | 19 | $9,679 | $509 |
| Estradiol | 42 | $2,002 | $48 |
| Raloxifene | 11 | $1,797 | $163 |
| Medroxyprogesterone Acetate | 19 | $398 | $21 |
| Alendronate | 12 | $135 | $11 |
2018: 7 drugs
| Estring | 15 | $7,307 | $487 |
| Estrace | 26 | $2,952 | $114 |
| Climara | 13 | $1,911 | $147 |
| Raloxifene | 11 | $1,769 | $161 |
| Oxybutynin Chloride | 11 | $1,224 | $111 |
| Medroxyprogesterone Acetate | 27 | $718 | $27 |
| Estradiol | 18 | $656 | $36 |
2017: 7 drugs
| Estrace | 30 | $9,527 | $318 |
| Estring | 16 | $7,063 | $441 |
| Climara | 13 | $1,705 | $131 |
| Oxybutynin Chloride | 13 | $1,529 | $118 |
| Medroxyprogesterone Acetate | 24 | $732 | $30 |
| Kelnor 1-35 | 13 | $405 | $31 |
| Alendronate | 14 | $199 | $14 |
2016: 4 drugs
| Estrace | 17 | $4,858 | $286 |
| Estring | 13 | $4,667 | $359 |
| Climara | 21 | $2,386 | $114 |
| Medroxyprogesterone Acetate | 17 | $356 | $21 |
2015: 6 drugs
| Estrace | 23 | $5,676 | $247 |
| Premarin | 16 | $4,230 | $264 |
| Vagifem | 11 | $3,880 | $353 |
| Climara | 24 | $2,726 | $114 |
| Oxybutynin Chloride Er | 11 | $1,428 | $130 |
| Medroxyprogesterone Acetate | 31 | $635 | $20 |
2014: 10 drugs
| Estring | 15 | $3,942 | $263 |
| Premarin | 18 | $3,628 | $202 |
| Estrace | 14 | $3,497 | $250 |
| Climara | 14 | $1,590 | $114 |
| Oxybutynin Chloride Er | 11 | $1,453 | $132 |
| Nystatin-Triamcinolone | 13 | $897 | $69 |
| Medroxyprogesterone Acetate | 26 | $525 | $20 |
| Estradiol | 18 | $253 | $14 |
| Alendronate | 14 | $209 | $15 |
| Acyclovir | 15 | $143 | $10 |
2013: 8 drugs
| Premarin | 40 | $7,077 | $177 |
| Estring | 26 | $6,347 | $244 |
| Oxybutynin Chloride Er | 12 | $1,856 | $155 |
| Climara | 16 | $1,709 | $107 |
| Nystatin-Triamcinolone | 15 | $879 | $59 |
| Estradiol | 31 | $834 | $27 |
| Medroxyprogesterone Acetate | 38 | $744 | $20 |
| Alendronate | 13 | $194 | $15 |
Professional record
- NPI
- 1780756528
- Licence
- CA G83161California G83161: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G831610
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-11-15
- NPI last updated
- 2022-01-10
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.